Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on focal cerebral ischemia in cat. - Suppr | 超能文献

Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on focal cerebral ischemia in cat.

作者信息

Okada M, Ueda H, Kometani M, Nakao K

机构信息

Drug Discovery Research Unit, Ciba-Geigy Japan Limited, Takarazuka, Japan.

出版信息

Arzneimittelforschung. 1997 Jun;47(6):703-5.

Abstract

The effect of the new competitive N-methyl-D-aspartate (NMDA) antagonist D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid (CAS 137424-81-8, CGP 40116) was examined in a cat model of focal cerebral ischemia. Effect of CGP 40116 was compared to that of another competitive NMDA antagonist, (+/-)-cis-4-phosphonomethyl-piperadine-2-carboxylic acid (CAS 110347-85-8, CGS 19755) under the same conditions. Drugs were administered intravenously 30 min before left middle cerebral artery (MCA) occlusion. After MCA occlusion for 8 h, infarction spreaded widely among caudate nucleus prepyriform cortex, amygdala and temporal lobe cortex in the ischemic hemisphere. CGP 40116 at the dose of 10 mg/kg and CGS 19755 at the dose of 30 mg/kg significantly decreased the infarcted area. CGP 40116 was effective in the frontal and central brain, although CGS 19755 showed neuroprotective effect in almost all sites. Thus, the compounds are potent neuroprotectants in focal ischemia.

摘要

相似文献

1

Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on focal cerebral ischemia in cat.

Arzneimittelforschung. 1997 Jun;47(6):703-5.

2

Neuroprotective effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid in the gerbil model of transient global cerebral ischemia.

Arzneimittelforschung. 1997 Jun;47(6):700-2.

3

Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on ischemic brain damage induced by four-vessel occlusion in rats.

Arzneimittelforschung. 1997 Feb;47(2):115-9.

4

The competitive NMDA receptor antagonist CGP 40116 is a potent neuroprotectant in a rat model of focal cerebral ischemia.

J Neural Transm Suppl. 1994;43:81-9.

5

Characterization of the cerebroprotective efficacy of the competitive NMDA receptor antagonist CGP40116 in a rat model of focal cerebral ischemia: an in vivo magnetic resonance imaging study.

J Cereb Blood Flow Metab. 1993 Jul;13(4):595-602. doi: 10.1038/jcbfm.1993.77.

6

Effects of the competitive N-methyl-D-aspartate antagonist CGP 37849 and its ethylester CGP 39551 on N-methyl-D-aspartate-evoked whole-cell currents in cultured spinal neurones and on vestibular stimulation-induced seizures in EL mice.竞争性N-甲基-D-天冬氨酸拮抗剂CGP 37849及其乙酯CGP 39551对培养的脊髓神经元中N-甲基-D-天冬氨酸诱发的全细胞电流以及EL小鼠前庭刺激诱发癫痫发作的影响。

Arzneimittelforschung. 1998 Dec;48(12):1121-5.

7

Neuroprotective effect of NMDA receptor glycine recognition site antagonism persists when brain temperature is controlled.当脑温得到控制时，N-甲基-D-天冬氨酸（NMDA）受体甘氨酸识别位点拮抗作用的神经保护效应依然存在。

J Cereb Blood Flow Metab. 1997 Feb;17(2):161-7. doi: 10.1097/00004647-199702000-00005.

8

Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists.

J Pharmacol Exp Ther. 1992 Nov;263(2):499-504.

9

Comparative analysis of brain protection by N-methyl-D-aspartate receptor antagonists after transient focal ischemia in cats.猫短暂局灶性缺血后N-甲基-D-天冬氨酸受体拮抗剂脑保护作用的比较分析

Crit Care Med. 1997 Jun;25(6):1037-43. doi: 10.1097/00003246-199706000-00022.

10

Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist.NPC 17742 [2R,4R,5S-(2-氨基-4,5-(1,2-环己基)-7-膦酰基庚酸)]的药理学特性，一种强效、选择性和竞争性N-甲基-D-天冬氨酸受体拮抗剂。

J Pharmacol Exp Ther. 1993 Jan;264(1):256-64.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。